Thu Jul 24 21:03:43 SGT 2014  
SINGAPORE
VD™
    VD genital warts, Singapore (SG)
HIV STD TESTING SINGAPORE™
Within 3 days after unprotected sex, stop HIV infection with Post-Exposure Prophylaxis treatment 10 days after unprotected sex, detect HIV infection with the DNA test 28 days after unprotected sex, accurately detect HIV infection with the 20 minute rapid test
Full & comprehensive sexually transmitted disease testing
Males: do not urinate for at least 4 hours before arriving
Females: testing is more accurate when you are not menstruating

VD genital warts, Singapore (SG) | HIV STD TESTING SINGAPORE™

Summary

VD genital warts, Singapore (SG) | HIV STD TESTING SINGAPORE™ @singaporevd_com: Genital warts (condyloma, condylomata acuminata, venereal wart, anal wart, anogenital wart, "cauliflower" sex disease) screening/diagnosis, testing/check treatment/removal/cure, Singapore. Private and confidential service. Definitions, references, and latest news.

Description

Genital warts: penile warts / vaginal warts / anal warts / anogenital warts / venereal warts / condyloma / condylomata acuminata / "cauliflower" sex disease.

References

Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
SHIM CLINIC
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: VD genital warts, Singapore (SG)
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.

Sexual risk (of HIV/STD/pregnancy), and what you can do before and after exposure.

Timeline Event / Available resources
HIV STD Pregnancy
Before exposure
Abstain from sex, Be faithful, or Condom use
Circumcision (males only)
Contraception
(females only)
HIV PrEP (pre-exposure prophylaxis) STD vaccine:
- Hepatitis vaccine
- HPV vaccine
STD / HIV exposure
Unsafe sex / unprotected sex:
No condom / Condom broke / Condom slip
0-72 hours HIV prevention
HIV PEP (post-exposure prophylaxis) treatment
- Stop HIV infection after exposure.
STD testing
If STD symptoms appear, then do STD treatment.
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.
Emergency contraception
(females only)
2 weeks HIV DNA PCR test
1 month 20 minute SD Bioline HIV Ag/Ab Combo HIV rapid test:
- Fingerprick blood sampling.
3 months 20 minute OraQuick® HIV rapid test:
- Oral saliva or
- Fingerprick blood sampling.
Full & comprehensive STD testing
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.

References


Latest News

Fewer Vulvar HPV Infections After HPV16/18 VaccineFewer Vulvar HPV Infections After HPV16/18 Vaccine
Tue, 22 Jul 2014 11:34:55 +0100 | Medscape Medical News Headlines
Women who receive the bivalent HPV16/18 vaccine have lower rates of vulvar human papillomavirus (HPV) infection, according to results from the Costa Rica Vaccine Trial. Reuters Health Information (Source: Medscape Medical News Headlines)

Human papillomavirus infection in Bhutan at the moment of implementation of a national HPV vaccination programme
Tue, 22 Jul 2014 00:00:00 +0100 | BMC Infectious Diseases
Background:

Starpharma's VivaGel HIV-killing condom 'could be available within months'
Mon, 21 Jul 2014 19:06:28 +0100 | the Mail online | Health
Tests have found the VivaGel condom, designed by Australian bio-tech firm Starpharma, is 99.9 per cent effective at deactivating HIV, herpes and human papilloma virus cases. (Source: the Mail online | Health)

Human Papillomavirus (HPV) Infection in Squamous Cell Carcinomas Arising From the Oropharynx: Detection of HPV DNA and p16 Immunohistochemistry as Diagnostic and Prognostic Indicators-A Pilot Study.
Mon, 21 Jul 2014 09:00:08 +0100 | Health Physics
CONCLUSION: Diagnostic methods based on the detection of HPV nucleic acids appear to be more reliable and objective because they do not require reading by a trained histopathologist. Furthermore, the detection of HPV DNA exhibits an improved correlation with survival, and therefore appears definitely more reliable than p16 IHC for routine use in clinical practice.

Two sisters reveal autosomal recessive inheritance of epidermodysplasia verruciformis: a case report
Mon, 21 Jul 2014 00:00:00 +0100 | BMC Dermatology
Conclusions:

Cervical cancer screening at crossroads
Mon, 21 Jul 2014 00:00:00 +0100 | APMIS
Cervical screening has been one of the most successful public health prevention programmes. For 50 years, cytology formed the basis for screening, and detected cervical intraepithelial lesions (CIN) were treated surgically to prevent progression to cancer. In a high‐risk country as Denmark, screening decreased the incidence of cervical cancer from 34 to 11 per 100 000, age‐standardized rate (World Standard Population). Screening is, however, also expensive; Denmark (population: 5.6 million) undertakes close to half a million tests per year, and has 6–8 CIN‐treated women for each prevented cancer case. The discovery of human papillomavirus (HPV) as the cause of cervical cancer dramatically changed perspectives for disease control. Screening with HPV testing was launched around 19...

Human papillomavirus-related psychosocial impact of patients with genital warts in China: a hospital-based cross-sectional study
Mon, 21 Jul 2014 00:00:00 +0100 | BMC Public Health - Latest articles
Conclusions:

Long‐term HPV type‐specific risks for high‐grade cervical intraepithelial lesions: A 14‐year follow‐up of a randomized primary HPV screening trial
Sat, 19 Jul 2014 19:24:33 +0100 | International Journal of Cancer
Abstract

Identification of human papillomavirus status specific biomarker in head and neck cancer
Sat, 19 Jul 2014 00:00:00 +0100 | Head and Neck
ConclusionThe identification of HPV status‐specific significant gene set was necessary. It is expected that HPV status‐specific biomarkers can be helpful in deciding therapeutic methods for patients with head and neck cancer, after biological validation and large prospective trials. © 2014 Wiley Periodicals, Inc. Head Neck, 2014 (Source: Head and Neck)

Negative HPV test may predict lower cervical cancer risk than a negative Pap
Fri, 18 Jul 2014 21:20:41 +0100 | ScienceDaily Headlines
In the US, cotesting for human papilloma virus and Pap testing for cervical cancer every 5 years for women aged 30-65 years is now recommended. However, human papilloma virus testing alone may provide better reassurance against cervical cancer than Pap testing alone and similar reassurance to cotesting, according to a study. (Source: ScienceDaily Headlines)